65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02733679
(ClinicalTrials.gov)
September 29, 201631/3/2016Response of Individuals With Ataxia-Telangiectasia to Metformin and PioglitazoneResponse of Individuals With Ataxia-Telangiectasia to Metformin and PioglitazoneAtaxia-TelangiectasiaDrug: Metformin;Drug: PioglitazoneNHS TaysideUniversity of DundeeCompleted18 Years30 YearsAll27Phase 4United Kingdom